ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Wynder Group Finds No Association Between Coffee, Pancreatic Cancer

August 19, 1983

NEJM Paper Ignites Debate Over Spiral CT Scans For Lung Cancer.

November 3, 2006

NCI Issues Statement On Endostatin Research

October 1, 1999

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

SWOG Plans Increase in Payments to Centers for Trial Accrual.

May 25, 2007

DCPC Forms Decision Network To oversee Chemoprevention

July 16, 1993